Bill Proposes Removal of Medical Marijuana from Controlled Substance Lists

Article

A bill introduced in the House of Representatives would exclude medical marijuana products from the Controlled Substances Act's definition of marijuana.

A bill introduced in the House of Representatives would exclude medical marijuana products from the Controlled Substances Act’s definition of marijuana.

A bill introduced in the House of Representatives July 28, 2014, proposes amending the definition of marijuana to exclude medical marijuana from controlled substance lists.

The Charlotte’s Web Medical Hemp Act of 2014 proposes excluding therapeutic hemp and cannabidiol from the Controlled Substances Act’s “definition of marihuana (sic),” according to a copy of the bill text available through the Library of Congress. The amendments specifically state that the therapeutic hemp and cannabidiol should not be treated as controlled substances under the act. It defines therapeutic hemp as Cannabis sativa L, and any part of that plant with a THC concentration lower than 0.3% on a dry weight basis. Cannabidiol refers to the substance derived from therapeutic hemp, the bill text continues.

In addition, the bill recommends excluding therapeutic hemp or cannabidiol from Federal Food, Drug, and Cosmetic Act sections covering controlled substances.

The bill further notes that its provisions do not restrict or prohibit use, production, or distribution activities in states where marijuana is legal under law.

Representatives Scott Perry (R-PA), Paul Broun (R-GA), Steve Cohen (D-TN), and Dana Rohrabacher (R-CA) sponsored the bill HR 5226. It was referred to the House Energy and Commerce Committee and House Judiciary Committee after its introduction, Govtrack.us states.

Medical marijuana remains under debate among the medical and law enforcement community, as Pharmacy Times Drug Diversion and Abuse columnist CMDR John Burke notes in his December 2013 column. If the substance is the “wonder drug” proponents claim, it should be subject to the same FDA approval process as traditional pharmaceuticals, and should be dispensed at the pharmacy, Burke suggests.

CMDR Burke revisited the medical marijuana topic in a sidebar accompanying his February 2014 Drug Diversion and Abuse column, which focused on edible marijuana products.

Pharmacy Times blogger Jay Sochoka, noting the increase in states approving medical marijuana, questions the reasons pharmacists are not in charge of dispensing medical cannabis. A follow-up blog addressed comments from his first blog, including the potential medical uses for the substance.

Related Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba | stock.adobe.com
Rear view of Audience listening Speakers on the stage in the conference hall or seminar meeting, business and education about investment concept -  Image credit: THANANIT | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.